The firm also operates a personalized medicine subsidiary developing assays based on the firm's Nucleic Acid Detection Immuno-Assay (NADiA) technology, which combines the specificity of monoclonal antibody capture with the sensitivity of real-time polymerase chain reaction detection. 14.Ĭhatsworth, Calif.-based Iris has three operating units: Iris Diagnostics, Iris Sample Processing, and Iris Molecular Diagnostics. The purchase price represents a 45 percent premium to Iris' closing stock price of $13.42 on Sept.
The total consideration being paid is $338 million including debt and net of cash acquired, said Danaher. NEW YORK (GenomeWeb News) – Danaher today said that it has signed definitive agreement to acquire diagnostics and sample prep technologies firm Iris International for $19.50 per share in cash. Advances in Clinical Genomics Profiling.
0 kommentar(er)
